Items tagged with Diagnostics
New blood test found to predict onset of TB up to two years in advance (post)
A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB, according to research published online in the American Journal of Respiratory and Critical Care Medicine, an American Thoracic Society journal.
New TB tools need to be affordable in the private sector: The case study of Xpert MTB/RIF (post)
A new 13-country patient pathway analysis published in the Journal of Epidemiology and Global Health presents updated data on what patients pay for Xpert MTB/RIF testing in the private health sector in highly privatized health markets.
Factsheet on TB diagnostics development (post)
The World Health Organization released a factsheet-advice to manufacturers on development and assessment of TB diagnostics.
New TB test cuts diagnosis time from months to hours (post)
Leading experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives in emerging countries.
Blood signature could improve early TB diagnosis (post)
A gene signature in the bloodstream could reveal whether someone is going to develop active tuberculosis (TB) disease months before symptoms begin. Such a signature has now been developed by a team led by the Francis Crick Institute and University of Leicester, in collaboration with BIOASTER and bioMérieux in France and the University of Cape Town in South Africa.
Co-Diagnostics receives CE mark for TB test kit (post)
SALT LAKE CITY, Jul. 25, 2018 -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test has obtained CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of tuberculosis in European Union states and other markets that accept a CE-IVD mark as valid regulatory approval.
Use of Xpert TB diagnostic tool linked to lower death rates from all causes among HIV patients entering care in Malawi study (post)
Study randomized clinics to use Xpert or fluorescence microscopy for patients newly diagnosed with HIV showing TB symptom.
TAG's TB Activist's Toolkits now available in Spanish (post)
In addition to the Russian translations, Spanish translations of An Activist’s Guide to Tuberculosis Diagnostic Tools and An Activist’s Guide to Tuberculosis Drugs are now also available.
Innovative diagnostic test for TB could save millions of lives (post)
LifeArc, the medical research charity, and the University of St Andrews Infection Group today (August 7) announced a partnership to develop a molecular diagnostic test for the detection and quantification of tuberculosis (TB) bacteria in patients.
Handbook on TB laboratory diagnostic methods in the European Union – updated 2018 (post)
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent TB infection.
Page 29 of 70 · Total posts: 0
←First 28 29 30 Last→